Total Payments
$289,573
2024 Payments
$40,506
Companies
10
Transactions
109
Medicare Patients
220
Medicare Billing
$68,845
Payment Breakdown by Category
Consulting$288,920 (99.8%)
Food & Beverage$482.36 (0.2%)
Travel$155.00 (0.1%)
Education$16.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $288,920 | 98 | 99.8% |
| Food and Beverage | $482.36 | 8 | 0.2% |
| Travel and Lodging | $155.00 | 1 | 0.1% |
| Education | $16.24 | 1 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$289,573
108 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cumberland Pharmaceuticals, Inc. | $225,025 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32,888 | 15 | $0 (2020) |
| SANOFI US SERVICES INC. | $23,540 | 7 | $0 (2024) |
| Baxter Healthcare | $7,314 | 7 | $0 (2022) |
| Janssen Research & Development, LLC | $450.00 | 1 | $0 (2020) |
| Fresenius Kabi USA, LLC | $152.56 | 1 | $0 (2023) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
| Solventum Corporation | $20.18 | 1 | $0 (2024) |
| ATRICURE, INC. | $18.24 | 1 | $0 (2021) |
| Insmed, Inc. | $16.24 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,506 | 15 | Cumberland Pharmaceuticals, Inc. ($36,153) |
| 2023 | $44,862 | 19 | Cumberland Pharmaceuticals, Inc. ($34,646) |
| 2022 | $40,551 | 17 | Cumberland Pharmaceuticals, Inc. ($30,750) |
| 2021 | $32,427 | 17 | Cumberland Pharmaceuticals, Inc. ($29,750) |
| 2020 | $36,075 | 9 | Cumberland Pharmaceuticals, Inc. ($29,675) |
| 2019 | $39,589 | 16 | Cumberland Pharmaceuticals, Inc. ($23,525) |
| 2018 | $37,788 | 11 | Cumberland Pharmaceuticals, Inc. ($22,750) |
| 2017 | $17,777 | 5 | Cumberland Pharmaceuticals, Inc. ($17,777) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $1,887.50 | General |
| 07/31/2024 | Solventum Corporation | ACTIV.A.C. (Device), PREVENA, V.A.C. VERAFLO | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 07/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/21/2024 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $111.34 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 01/05/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $2,445.00 | General |
| 01/01/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 2024 | Cumberland Pharmaceuticals, Inc. | — | — | — | $0.00 | Ownership |
| 12/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2023 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $152.56 | General |
| Category: Parental Nutrition | ||||||
| 05/01/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $2,291.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/20/2023 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug), SANCUSO, VAPRISOL DEXTROSE IN PLASTIC CONTAINER | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 78 | $58,076 | $10,052 |
| 2022 | 2 | 54 | 118 | $73,260 | $17,311 |
| 2021 | 1 | 42 | 109 | $75,755 | $17,869 |
| 2020 | 3 | 78 | 167 | $99,064 | $23,613 |
Total Patients
220
Total Services
472
Medicare Billing
$68,845
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 55 | $51,107 | $8,708 | 17.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 23 | $6,969 | $1,344 | 19.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 39 | 96 | $67,188 | $15,748 | 23.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 22 | $6,072 | $1,563 | 25.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 42 | 109 | $75,755 | $17,869 | 23.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 53 | 130 | $90,350 | $21,004 | 23.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 23 | $6,348 | $1,879 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 14 | $2,366 | $730.06 | 30.9% |
About Dr. Todd Rice, MD
Dr. Todd Rice, MD is a Critical Care Medicine healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558458687.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Rice, MD has received a total of $289,573 in payments from pharmaceutical and medical device companies, with $40,506 received in 2024. These payments were reported across 109 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($288,920).
As a Medicare-enrolled provider, Rice has provided services to 220 Medicare beneficiaries, totaling 472 services with total Medicare billing of $68,845. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Location Nashville, TN
- Active Since 10/09/2006
- Last Updated 03/31/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1558458687
Products in Payments
- KRISTALOSE (Drug) $101,438
- CALDOLOR (Drug) $29,861
- IPS - Nutrition (Biological) $4,014
- IPS - Nutrition (Device) $3,300
- Smoflipid (Drug) $152.56
- ZERBAXA (Drug) $150.00
- ACTIV.A.C. (Device) $20.18
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $18.24
- Arikayce (Drug) $16.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Nashville
Joao Deandrade, Md, MD
Critical Care Medicine — Payments: $335,274
Critical Care Medicine $335,274
Dr. Aniket Rali, M.d, M.D
Critical Care Medicine — Payments: $47,214
Critical Care Medicine $47,214
Jamie Deneau, Aprn Ms Ccns, APRN MS CCNS
Critical Care Medicine — Payments: $28,796
Critical Care Medicine $28,796
Elliott Cohen, Md, MD
Critical Care Medicine — Payments: $21,618
Critical Care Medicine $21,618
Angelo Canonico, M.d, M.D
Critical Care Medicine — Payments: $18,438
Critical Care Medicine $18,438
Mr. Salim Mehio, Md, MD
Critical Care Medicine — Payments: $16,330
Critical Care Medicine $16,330